Neal Shore MD CPI,FACS

Clinical Trials

• MCS in the Treatment of Lower Urinary Tract Symptoms Start of enrollment: 2010 Jul 01

  Completed

  Phase 2, Phase 3

• A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer Start of enrollment: 2012 Dec 01

  Terminated

  Phase 2

• Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01

  Terminated

• UroLift System TOlerability and ReCovery When Administering Local Anesthesia Start of enrollment: 2013 Apr 01

  Completed

  Not Applicable

• Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01

  Terminated

• A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT Start of enrollment: 2013 Dec 01

  Terminated

  Phase 1, Phase 2

• A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2011 Dec 01

  Completed

  Phase 2

• Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis Start of enrollment: 2014 Mar 01

  Completed

  Phase 2

• Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2014 May 26

  Completed

  Phase 3

• Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC Start of enrollment: 2013 Aug 01

  Completed

• Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery Start of enrollment: 2014 Oct 01

  Terminated

  Phase 2

• Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma Start of enrollment: 2014 Aug 01

  Completed

  Phase 3

• PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study Start of enrollment: 2014 Sep 01

  Terminated

• Maintaining Suppression of Testosterone With Transdermal Estradiol Gel Start of enrollment: 2015 Jul 01

  Terminated

  Phase 2

• A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2014 Jun 01

  Completed

  Phase 1, Phase 2

• A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer Start of enrollment: 2015 Apr 29

  Completed

  Phase 2

• Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. Start of enrollment: 2015 May 01

  Completed

  Phase 2

• Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG Start of enrollment: 2015 Aug 01

  Completed

  Phase 3

• Pivotal Study to Assess the Safety and Effectiveness of the iTind Device Start of enrollment: 2015 Jul 01

  Completed

  Not Applicable

• Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis Start of enrollment: 2015 Sep 23

  Completed

  Phase 2

• Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer Start of enrollment: 2015 Jul 01

  Completed

  Phase 1

• Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg Start of enrollment: 2016 Feb 01

  Completed

  Phase 3

• Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients Start of enrollment: 2016 Dec 01

  Completed

  Phase 1

• Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI Start of enrollment: 2021 Dec 15

  COMPLETED

  NA

  Roles: Contact

• Join now to see all